USA TODAY - Crestor ads draw fire; FDA could act
AstraZeneca, Europe’s second-largest drugmaker, has presented a comprehensive, 30-page response to the US Food and Drug Administration urging the agency to remove Public Citizen’s Health Research Group’s petition to ban its cholesterol-lowering drug Crestor (rosuvastatin) from the market, saying that it provides no scientific basis, is inaccurate and must be denied.
Related Results
Evening Standard, London, Market Report Column.
US scientist casts doubt on AstraZeneca’s Crestor
AstraZeneca’s Crestor off to strong start in USA; overall performance on track.
AstraZeneca warns of delay to Crestor launch
US scientist casts doubt on AstraZeneca’s Crestor
According to AstraZeneca, the …
Want to read the whole article? You can purchase it here. It’s quick and easy.
